Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Services
1.2.4. Workflow
1.2.5. Therapeutic Area
1.2.6. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.3. R&D Spending Analysis
3.4. Industry Ecosystem Analysis
3.4.1. Demand Analysis
3.4.2. Supply Chain Analysis
3.5. Technology Landscape
3.6. Clinical Trial Volume Analysis, 2024
3.7. Pricing Analysis
3.8. Tariff and Trade Agreement Impact Analysis
3.9. Value Chain Analysis
3.9.1. Supply Trends
3.9.2. Demand Trends
3.10. Market Analysis Tools
3.10.1. Porter’s Five Forces Analysis
3.10.2. PESTEL by SWOT Analysis
Chapter 4. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Type Estimates & Trend Analysis
4.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Type: Segment Dashboard
4.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Type: Movement Analysis
4.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Type, 2021-2033 (USD Million)
4.4. Small Molecule
4.4.1. Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Branded
4.4.2.1. Branded Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Generic
4.4.3.1. Generic Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Large Molecule
4.5.1. Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Biologics
4.5.2.1. Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Biosimilar
4.5.3.1. Biosimilar Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Product Estimates & Trend Analysis
5.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Product: Segment Dashboard
5.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Product: Movement Analysis
5.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Product, 2021-2033 (USD Million)
5.4. API
5.4.1. API Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2. Traditional Active Pharmaceutical Ingredient (Traditional API)
5.4.2.1. Traditional Active Pharmaceutical Ingredient (Traditional API) Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3. Highly Potent Active Pharmaceutical Ingredient (HP-API)
5.4.3.1. Highly Potent Active Pharmaceutical Ingredient (HP-API) Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.4. Biologics
5.4.4.1. Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.5. Others
5.4.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Drug Product
5.5.1. Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.2. Oral Solid Dose
5.5.2.1. Oral Solid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.3. Semi-Solid Dose
5.5.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.4. Liquid Dose
5.5.4.1. Liquid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.5. Others
5.5.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Service Estimates & Trend Analysis
6.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Service: Segment Dashboard
6.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Service: Movement Analysis
6.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Service, 2021-2033 (USD Million)
6.4. Contract Development
6.4.1. Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. Pre-formulation & Formulation Development Services
6.4.2.1. Pre-formulation & Formulation Development Services Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Process Development & Optimization
6.4.3.1. Process Development & Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. Analytical Testing & Method Validation
6.4.4.1. Analytical Testing & Method Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. Scale-up & Tech Transfer
6.4.5.1. Scale-up & Tech Transfer Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Contract Manufacturing
6.5.1. Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. API Manufacturing
6.5.2.1. API Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Finished Drug Products Manufacturing
6.5.3.1. Finished Drug Products Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Packaging and Labelling
6.6.1. Packaging and Labelling Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Regulatory Affairs
6.7.1. Regulatory Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Others
6.8.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Workflow Estimates & Trend Analysis
7.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Workflow: Segment Dashboard
7.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Workflow: Movement Analysis
7.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Workflow, 2021-2033 (USD Million)
7.4. Clinical
7.4.1. Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Commercial
7.5.1. Commercial Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Therapeutic Area Estimates & Trend Analysis
8.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Therapeutic Area: Segment Dashboard
8.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by Therapeutic Area: Movement Analysis
8.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Therapeutic Area, 2021-2033 (USD Million)
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Infectious Diseases
8.5.1. Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Neurological Disorders
8.6.1. Neurological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7. Cardiovascular Diseases
8.7.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.8. Metabolic Disorders
8.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
8.9. Autoimmune Diseases
8.9.1. Autoimmune Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.10. Respiratory Diseases
8.10.1. Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.11. Ophthalmology
8.11.1. Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
8.12. Gastrointestinal Disorders
8.12.1. Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
8.13. Orthopedic Diseases
8.13.1. Orthopedic Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.14. Dental Diseases
8.14.1. Dental Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.15. Others
8.15.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: End Use Estimates & Trend Analysis
9.1. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by End Use: Segment Dashboard
9.2. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market, by End Use: Movement Analysis
9.3. U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Estimates & Forecasts, by End Use, 2021-2033 (USD Million)
9.4. Small Pharmaceutical Companies
9.4.1. Small Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5. Medium Pharmaceutical Companies
9.5.1. Medium Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6. Large Pharmaceutical Companies
9.6.1. Large Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Key Participant Categorization
10.1.1. Market Leaders
10.1.2. Emerging Players
10.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific, Inc
10.3.1.1. Company Overview
10.3.1.2. Financial Performance
10.3.1.3. Service Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. Lonza
10.3.2.1. Company Overview
10.3.2.2. Financial Performance
10.3.2.3. Service Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. Recipharm AB
10.3.3.1. Company Overview
10.3.3.2. Financial Performance
10.3.3.3. Service Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. Catalent, Inc
10.3.4.1. Company Overview
10.3.4.2. Financial Performance
10.3.4.3. Service Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. WuXi AppTec, Inc
10.3.5.1. Company Overview
10.3.5.2. Financial Performance
10.3.5.3. Service Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. Samsung Biologics
10.3.6.1. Company Overview
10.3.6.2. Financial Performance
10.3.6.3. Service Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. Piramal Pharma Solutions
10.3.7.1. Company Overview
10.3.7.2. Financial Performance
10.3.7.3. Service Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. Siegfried Holding AG
10.3.8.1. Company Overview
10.3.8.2. Financial Performance
10.3.8.3. Service Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. Corden Pharma International
10.3.9.1. Company Overview
10.3.9.2. Financial Performance
10.3.9.3. Service Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. Cambrex Corporation
10.3.10.1. Company Overview
10.3.10.2. Financial Performance
10.3.10.3. Service Benchmarking
10.3.10.4. Strategic Initiatives
10.3.11. Vetter Pharma
10.3.11.1. Company Overview
10.3.11.2. Financial Performance
10.3.11.3. Service Benchmarking
10.3.11.4. Strategic Initiatives
10.3.12. Delpharm
10.3.12.1. Company Overview
10.3.12.2. Financial Performance
10.3.12.3. Service Benchmarking
10.3.12.4. Strategic Initiatives
10.3.13. Jubilant Pharmova / HollisterStier
10.3.13.1. Company Overview
10.3.13.2. Financial Performance
10.3.13.3. Service Benchmarking
10.3.13.4. Strategic Initiatives
10.3.14. Eurofins CDMO
10.3.14.1. Company Overview
10.3.14.2. Financial Performance
10.3.14.3. Service Benchmarking
10.3.14.4. Strategic Initiatives
10.3.15. Almac Pharma Services
10.3.15.1. Company Overview
10.3.15.2. Financial Performance
10.3.15.3. Service Benchmarking
10.3.15.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 4 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 5 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 6 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Workflow, 2021-2033 (USD Million)
Table 7 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by Therapeutic Area, 2021-2033 (USD Million)
Table 8 U.S. Pharmaceutical Contract Development And Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Type outlook and key takeaways
Figure 20 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Type movement analysis
Figure 21 Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Branded Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Generic Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Biosimilar Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Product outlook and key takeaways
Figure 28 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Product movement analysis
Figure 29 Pharmaceutical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 API Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Traditional API Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 32 HP-API Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Oral Solid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Semi-Solid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Liquid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Service outlook and key takeaways
Figure 41 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Service movement analysis
Figure 42 Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Pre-formulation & Formulation Development Service Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Process Development & Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Analytical Testing & Method Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Scale-up & Tech Transfer Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 API Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Finished Drug Products Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Packaging and Labelling Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Regulatory Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Workflow outlook and key takeaways
Figure 54 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Workflow movement analysis
Figure 55 Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 Commercial Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Therapeutic Area outlook and key takeaways
Figure 58 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: Therapeutic Area movement analysis
Figure 59 Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Neurological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Metabolic Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Autoimmune Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 65 Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Orthopedic Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 69 Dental Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 71 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: End Use outlook and key takeaways
Figure 72 U.S. Pharmaceutical Contract Development and Manufacturing Organization Market: End Use movement analysis
Figure 73 Small Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 74 Medium Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 75 Large Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 76 Key company categorization
Figure 77 Service heat map analysis
Figure 78 Strategic framework
